ORRAF(ORRAF)
ORRAF
No analyst ratings available
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|
| Revenue Avg | $2.31B | $2.39B | $2.48B | $2.61B |
| Low | $2.24B | $2.28B | $2.39B | $2.51B |
| High | $2.36B | $2.54B | $2.59B | $2.72B |
| EBITDA Avg | $404M | $428M | $449M | $469M |
| Low | $396M | $418M | $438M | $457M |
| High | $413M | $438M | $460M | $481M |
| EBIT Avg | $233M | $259M | $280M | $298M |
| Low | $225M | $249M | $269M | $287M |
| High | $242M | $269M | $291M | $310M |
| Net Income Avg | $132M | $154M | $171M | $187M |
| Low | $125M | $146M | $162M | $177M |
| High | $140M | $162M | $181M | $197M |
| EPS Avg | $0.11 | $0.12 | $0.14 | $0.15 |
| Low | $0.10 | $0.12 | $0.13 | $0.14 |
| High | $0.11 | $0.13 | $0.15 | $0.16 |
| Analysts (Rev / EPS) | 12 / 1 | 12 / 1 | 9 / 1 | 6 / 1 |